Product Code: GVR-4-68039-942-4
Kyphoplasty Market Growth & Trends
The global kyphoplasty market size is expected to reach USD 950.8 million by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 5.3% from 2023 to 2030. The increasing geriatric population is a key contributing factor attributable to the market growth during the forecast period. Compression fractures affect many individuals worldwide. Vertebral compression fractures (VCFs) are the most common fracture in osteoporosis patients, affecting approximately 750,000 people every year. The occurrence of this condition gradually rises as people age, with an estimated 40% of women aged 80 and older affected.
During the outbreak of COVID-19, non-emergency procedures have significantly impacted the Kyphoplasty market. As restrictions resulted in delays to a number of procedures. Most nations have elevated restrictions on elective surgery. In April 2020, the North American Spine Society (NASS) released a guidance document comprehensive of clinical considerations and recommendations for surgeries and procedures within the following classes: emergent, urgent, and elective. As a result, it is estimated to drive market growth after the recommencement of surgical procedures at full force.
The COVID-19 pandemic has significantly affected the surgical and clinical practice of spine surgeons across the globe. As per an Asia Pacific Spine Society (APSS) Survey, the COVID-19 pandemic had changed spine surgeons' clinical practices. The study intended to examine the impact of the pandemic on the clinical practices of spine surgeons within the Asia Pacific region. A total of 222 respondents from 19 nations completed the questionnaire. The study resulted in the mean reduction of clinic volume for all nations was 48.1%. Thus, there was a substantial decrease in the number of surgeries performed in Malaysia, Japan, India, the Philippines, and South Korea.
Kyphoplasty can offer faster pain relief and enhanced functional outcomes compared with conservative treatment. Multiple myeloma, one of the cancer form weaken the bones of the back, which leads to fractures and kyphosis. While continuous sitting and bad posture can be the reason for the development of kyphosis. It develops because sitting puts substantial pressure on the vertebrae, wearing them down.
Increasing demand for minimally invasive surgical procedures, improving health reimbursement, technological advancement in new products, and increasing incidence of osteoporosis are other factors expected to promote the market growth during the forecast period. For instance, in September 2020, Stryker's SpineJack implantable fracture reduction system received the U.S. Centers for Medicare & Medicaid Services (CMS) new technology add-on payment as part of the 2021 inpatient prospective payment system.
Kyphoplasty Market Report Highlights
- Bone access devices segment was the largest revenue-generating segment of the market in 2022 owing to the rising prevalence of spine fractures, back pain
- Balloon catheters segment is anticipated to witness lucrative growth. The increasing number of technological advancements with the beginning of next-generation kyphoplasty balloons supports segment growth
- On the basis of application, the spinal fractures segment held the largest market share and witnessed lucrative growth over the forecast period. Rising incidences of compressed bones of the spine due to cancer, and trauma has led to the growth of the segment
- Osteoporosis segment dominated the overall market in terms of revenue in 2022. The increasing prevalence of osteoporosis is expected to lead the segment to its large market share over the other segment
- Hospitals segment held the largest market share in 2022. Technologically-advanced medical devices are being used extensively in hospitals, thus supports in market growth
- North America dominated in 2022 due to the presence of established manufacturers and a well-developed reimbursement structure in the region
- The market is highly competitive in nature as major players are focusing on the product innovation strategies due to changing needs of surgeons and patients
- In May 2020, Medtronic launched its Kyphon Assist Directional Cannula in the U.S. for assisting its other kyphoplasty products for the treatment of vertebral compression fractures caused due to osteoporosis, benign lesions, or cancer. Thereby, expanding its product portfolio
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.1.1. Product
- 1.1.2. Application
- 1.1.3. Indication
- 1.1.4. End-use
- 1.1.5. Regional scope
- 1.1.6. Estimates and forecast timeline
- 1.2. Research Methodology
- 1.3. Information Procurement
- 1.3.1. Purchased database
- 1.3.2. GVR's internal database
- 1.3.3. Secondary sources
- 1.3.4. Primary research
- 1.4. Information or Data Analysis
- 1.4.1. Data analysis models
- 1.5. Market Formulation & Validation
- 1.6. Model Details
- 1.7. List of Secondary Sources
- 1.8. List of Primary Sources
- 1.9. Objectives
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Product outlook
- 2.2.2. Application outlook
- 2.2.3. Indication
- 2.2.4. End-Use
- 2.2.5. Regional outlook
- 2.3. Competitive Insights
Chapter 3. Kyphoplasty Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Penetration & Growth Prospect Mapping
- 3.3. Industry Value Chain Analysis
- 3.3.1. Reimbursement framework
- 3.4. Market Dynamics
- 3.4.1. Market driver analysis
- 3.4.2. Market restraint analysis
- 3.5. Kyphoplasty Market Analysis Tools
- 3.5.1. Industry Analysis - Porter's
- 3.5.1.1. Supplier power
- 3.5.1.2. Buyer power
- 3.5.1.3. Substitution threat
- 3.5.1.4. The threat of new entrants
- 3.5.1.5. Competitive rivalry
- 3.5.2. PESTEL Analysis
- 3.5.2.1. Political landscape
- 3.5.2.2. Technological landscape
- 3.5.2.3. Economic landscape
Chapter 4. Kyphoplasty: Product Estimates & Trend Analysis
- 4.1. Kyphoplasty Market: Key Takeaways
- 4.2. Kyphoplasty Market: Movement & Market Share Analysis, 2022 & 2030
- 4.3. Balloon Catheters
- 4.3.1. Balloon catheters market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.4. Bone Access Devices
- 4.4.1. Bone access devices market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.5. Cement Application Products
- 4.5.1. Cement application products market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.6. Bone Cement
- 4.6.1. Bone cements market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.7. Cement Mixing System
- 4.7.1. Cement mixing system market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.8. Instruments
- 4.8.1. Instruments market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Kyphoplasty: Application Estimates & Trend Analysis
- 5.1. Kyphoplasty Market: Key Takeaways
- 5.2. Kyphoplasty Market: Movement & Market Share Analysis, 2022 & 2030
- 5.3. Vertebral Alignment Restoration
- 5.3.1. Vertebral alignment restoration market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.4. Spinal Fractures
- 5.4.1. Spinal fractures market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.5. Kyphosis
- 5.5.1. Kyphosis market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. Kyphoplasty: Indication Estimates & Trend Analysis
- 6.1. Kyphoplasty Market: Key Takeaways
- 6.2. Kyphoplasty Market: Movement & Market Share Analysis, 2022 & 2030
- 6.3. Osteoporosis
- 6.3.1. Osteoporosis market estimates and forecasts, 2018 to 2030 (USD Million)
- 6.4. Others
- 6.4.1. Other market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 7. Kyphoplasty: End-use Estimates & Trend Analysis
- 7.1. Kyphoplasty Market: Key Takeaways
- 7.2. Kyphoplasty Market: Movement & Market Share Analysis, 2022 & 2030
- 7.3. Hospitals & Clinics
- 7.3.1. Hospitals and clinics market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.4. Ambulatory Surgical Centers (ASCs)
- 7.4.1. Ambulatory surgical centers market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 8. Kyphoplasty Market: Regional Estimates & Trend Analysis
- 8.1. Regional Outlook
- 8.2. Kyphoplasty Market by Region: Key Marketplace Takeaway
- 8.3. North America
- 8.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 8.3.2. The U.S.
- 8.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 8.3.3. Canada
- 8.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 8.4. Europe
- 8.4.1. UK
- 8.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 8.4.2. Germany
- 8.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 8.4.3. France
- 8.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 8.4.4. Italy
- 8.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 8.4.5. Spain
- 8.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 8.4.6. Sweden
- 8.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 8.4.7. Norway
- 8.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 8.4.8. Denmark
- 8.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 8.5. Asia Pacific
- 8.5.1. Japan
- 8.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 8.5.2. China
- 8.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 8.5.3. India
- 8.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 8.5.4. Australia
- 8.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 8.5.5. Thailand
- 8.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 8.5.6. South Korea
- 8.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 8.6. Latin America
- 8.6.1. Brazil
- 8.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 8.6.2. Mexico
- 8.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 8.6.3. Argentina
- 8.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 8.7. MEA
- 8.7.1. Saudi Arabia
- 8.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 8.7.2. South Africa
- 8.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 8.7.3. UAE
- 8.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 8.7.4. Kuwait
- 8.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
Chapter 9. Competitive Landscape
- 9.1. Recent Developments & Impact Analysis, By Key Market Participants
- 9.2. Market Participant Categorization
- 9.2.1. STRYKER
- 9.2.1.1. Company overview
- 9.2.1.2. Financial performance
- 9.2.1.3. Product benchmarking
- 9.2.1.4. Strategic initiatives
- 9.2.2. MEDTRONIC
- 9.2.2.1. Company overview
- 9.2.2.2. Financial performance
- 9.2.2.3. Product benchmarking
- 9.2.2.4. Strategic initiatives
- 9.2.3. SMITH + NEPHEW
- 9.2.3.1. Company overview
- 9.2.3.2. Financial performance
- 9.2.3.3. Product benchmarking
- 9.2.3.4. Strategic initiatives
- 9.2.4. MICROPORT SCIENTIFIC CORPORATION
- 9.2.4.1. Company overview
- 9.2.4.2. Financial performance
- 9.2.4.3. Product benchmarking
- 9.2.4.4. Strategic initiatives
- 9.2.5. DEPUY SYNTHES (JOHNSON & JOHNSON SERVICES INC.)
- 9.2.5.1. Company overview
- 9.2.5.2. Financial performance
- 9.2.5.3. Product benchmarking
- 9.2.5.4. Strategic initiatives
- 9.2.6. IZI Medical Products
- 9.2.6.1. Company overview
- 9.2.6.2. Financial performance
- 9.2.6.3. Product benchmarking
- 9.2.6.4. Strategic initiatives
- 9.2.7. CAREFUSION (A BD COMPANY)
- 9.2.7.1. Company overview
- 9.2.7.2. Financial performance
- 9.2.7.3. Product benchmarking
- 9.2.7.4. Strategic initiatives
- 9.2.8. MERIT MEDICAL SYSTEMS
- 9.2.8.1. Company overview
- 9.2.8.2. Financial performance
- 9.2.8.3. Product benchmarking
- 9.2.8.4. Strategic initiatives
- 9.2.9. JOIMAX GMBH
- 9.2.9.1. Company overview
- 9.2.9.2. Financial performance
- 9.2.9.3. Product benchmarking
- 9.2.9.4. Strategic initiatives
- 9.2.10. G21 S.R.L.
- 9.2.10.1. Company overview
- 9.2.10.2. Financial performance
- 9.2.10.3. Product benchmarking
- 9.2.10.4. Strategic initiatives
- 9.2.11. JOLINE GMBH & CO.KG
- 9.2.11.1. Company overview
- 9.2.11.2. Financial performance
- 9.2.11.3. Product benchmarking
- 9.2.11.4. Strategic initiatives
- 9.2.12. SEAWON MEDITECH
- 9.2.12.1. Company overview
- 9.2.12.2. Financial performance
- 9.2.12.3. Product benchmarking
- 9.2.12.4. Strategic initiatives
- 9.2.13. HENSLER SURGICAL PRODUCTS
- 9.2.13.1. Company overview
- 9.2.13.2. Financial performance
- 9.2.13.3. Product benchmarking
- 9.2.13.4. Strategic initiatives
- 9.2.14. TAEYEON MEDICAL
- 9.2.14.1. Company overview
- 9.2.14.2. Financial performance
- 9.2.14.3. Product benchmarking
- 9.2.14.4. Strategic initiatives
- 9.2.15. IMEDICOM
- 9.2.15.1. Company overview
- 9.2.15.2. Financial performance
- 9.2.15.3. Product benchmarking
- 9.2.15.4. Strategic initiatives
- 9.2.16. JIANGSU CHANGMEI MEDTECH CO., LTD
- 9.2.16.1. Company overview
- 9.2.16.2. Financial performance
- 9.2.16.3. Product benchmarking
- 9.2.16.4. Strategic initiatives